Navigation Links
New Medicare model guidelines for benefit years 2012-2014 in development
Date:10/4/2010

Rockville, Md., October 4, 2010 As the Medicare Model Guidelinesa listing of therapeutic categories and pharmacologic classes that Medicare Part D plans can utilize when developing their formulariesundergo revision for the first time in three years, the U.S. Pharmacopeial Convention (USP) is announcing its revision schedule and the expanded opportunities for public input as it develops Version 5.0.

Medicare Model Guidelines Version 5.0 will be available for utilization by prescription drug plans for the plan years 2012�. USP, a nonprofit scientific organization that sets federally recognized standards for the quality of medicines, was charged with developing the guidelines for the Centers for Medicare and Medicaid Services (CMS) under the Medicare Prescription Drug Improvement and Modernization Act of 2003.

USP has maintained a public comment process and one-on-one manufacturer consultations for developing the USP Model Guidelines since the beginning of this activity in 2004. In this revision cycle, USP is initiating new public Open Microphone Web meetings to solicit specific feedback on the content and organization of the USP Model Guidelines (to be held November 4, 8, 11 and 16, 2010). The one-on-one manufacturer consultations will be held October 4󈝿, 2010, and are an opportunity for manufacturers to schedule 30-minute scientific and clinical presentations with USP scientific staff to present information related to their medicines. Information related to these activities can be found on www.usp.org, under "Model Guidelines."

The Medicare Model Guidelines, which were initially released annually, will be developed by the USP Model Guidelines Expert Panel consisting of clinical pharmacists and pharmacologists, formulary specialists, health care practitioners and academicians, providers, beneficiaries and other volunteer experts. The panel will deliberate on the categories and classes to be included in Version 5.0 to be used as a resource by drug plans, reviewing current scientific evidence related to newly approved drugs and indications.

The Expert Panel will release the draft USP Model Guidelines Version 5.0 for public comment through the USP Web site (www.usp.org) on November 1, 2010, commencing a 30-day public comment period closing November 30, 2010. The draft USP Model Guidelines Version 5.0 will be presented to USP's Nomenclature, Safety and Labeling Expert Committee, the Expert Committee to which the Expert Panel reports, for approval in mid-January 2011. The final USP Medicare Model Guidelines Version 5.0 will be presented to CMS in late January 2011, and posted on the USP Web site in early February 2011.


'/>"/>

Contact: Francine Pierson
fp@usp.org
301-816-8588
US Pharmacopeia
Source:Eurekalert

Related medicine news :

1. Medicare Cost-Saving Moves Can Backfire
2. Connecture, Inc. Announces Partnership with MedicareCRM
3. Medicare data reveals differences in orthopedic surgical outcomes
4. Hayes Announces Appointment Of Dr Susan Levine To The Medicare Evidence Development and Coverage Advisory Committee (MEDCAC)
5. Georgia Senators Urged to Stop Medicare Cut Before March 1 Deadline
6. Top-Rated Medicare Advantage Plan Reaches 27,000-Member Milestone
7. Pelosi Statement on Additional Aid to States In Medicare Part D Payments
8. Medicare Advantage Members May Make Changes During Open Enrollment
9. Partners Home Care Scores in Top Tier in National Medicare Demonstration Project
10. Study Suggests Low-Consuming Medicare Beneficiaries With Chronic Disease Are More Costly to Program
11. Senate Inaction On Medicare Hurts Seniors, Military and Boomers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2016)... ... ... The joy associated with Mother’s Day is mixed with worry and fear for new mothers ... the country. For the first time ever, the March of Dimes and ... Mother’s Day beside a crib surrounded by lifesaving equipment or peering through a glass window ...
(Date:5/6/2016)... Jupiter, FL (PRWEB) , ... May 06, 2016 ... ... it will feature AsedaSciences® in an upcoming episode, airing third quarter 2016, via ... with the vision of becoming a leader in optimized drug discovery through innovative ...
(Date:5/6/2016)... ... , ... From the Speaker Podium to the Exhibit Floor at Booth#514, Worldwide ... managing Customers Engagement at SpeechTek 2016 Event, taking place May 23-25 at the Omni ... Presentation on “5 Customer Engagement Strategies to improve Customer Satisfaction in your Contact ...
(Date:5/6/2016)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has written a new article ... Bible about helping to stop cancer. Yisrayl says there are too many suffering and dying ... and science industries will pay close attention and take action. The Pastor says that the ...
(Date:5/6/2016)... ... May 06, 2016 , ... “ Crossing Over: Affirmations ... accounts of dying patients who have allowed those holding vigil to glimpse into the ... BSN, CHPN, hopes to help readers spiritually and practically gain insight into providing care ...
Breaking Medicine News(10 mins):
(Date:5/5/2016)... Research and Markets has ... Market and Competitive Landscape Highlights - 2016" ... (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ) The ... Landscape Highlights - 2016, provides comprehensive insights ... market valuations and forecast, Thalassaemia products sales ...
(Date:5/4/2016)...  Compass Diversified Holdings (NYSE: CODI ) ... leading middle market businesses, announced today its consolidated operating ... First Quarter 2016 Highlights , Generated ... "Cash Flow") of $13.6 million for the first quarter ... million for the first quarter of 2016; , ...
(Date:5/4/2016)... time for an upgrade. There are many medical recorders on the market but none ... DVMAXX HD  offers unparalleled connectivity and functionality.  Ampronix  is a renowned authorized reseller ... innovative technology.  Photo - http://photos.prnewswire.com/prnh/20160503/363416 ... ... ...
Breaking Medicine Technology: